Tails - Agree and disagree with you on sponsorship on KEVETRIN. To me the further they go on their own the more value is retained by the company and us with what we believe will become a proven drug. A sponsor at this time may be nice but would hope their use would be in expanding different phase trials for it's use against cancer. DF alone is good enough for the ovarian cancer trials. Keep in mind other institutions are borrowing KEVETRIN for their own in-house trials too. In time Kevetrin could prove to be one of the overall game changers in cancer treatments. My guess - no later than 2020